Literature DB >> 7224388

Cryptococcal intracerebral mass lesions: the role of computed tomography and nonsurgical management.

N K Fujita, M Reynard, F L Sapico, L B Guze, J E Edwards.   

Abstract

Cephalic computed tomography (CT) is a sensitive technique for defining certain intracerebral diseases. Four patients with cryptococcosis were evaluated with cephalic computed tomography over 3 years. All had focal, intracerebral "contrast-enhanced" lesions consistent with cryptococcal mass lesions, confirmed histopathologically in two. An analysis of 55 cases of cryptococcal intracerebral mass lesions from the literature showed that 18% of patients with these lesions associated with cryptococcal meningitis did not have specific symptoms or signs of focal intracerebral disease or increased intracranial pressure. We therefore recommend that patients with cryptococcal meningitis, regardless of localizing symptoms or signs, be considered for cephalic CT evaluation to ascertain the presence of mass lesions. Three patients in this report were treated with systemic antifungal medication without surgery. Decreased size or disappearance of these lesions was seen on sequential CT scan in all patients. We conclude that selected patients with cryptococcal intracerebral mass lesions may be managed successfully with systemic antifungal therapy alone.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7224388     DOI: 10.7326/0003-4819-94-3-382

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  Gd-DTPA-enhanced MR imaging of cryptococcal meningoencephalitis.

Authors:  A Takasu; M Taneda; H Otuki; Y Okamoto; K Oku
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Cryptococcal granuloma of the brain.

Authors:  C Keohane; R J Galvin; T F Buckley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

3.  Case report 268. Diagnosis: cryptococcal osteomyelitis of the calvaria.

Authors:  J W Reinig; G D Hungerford; M E Mohrmann; C L Vera
Journal:  Skeletal Radiol       Date:  1984       Impact factor: 2.199

4.  Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis.

Authors:  P Bayardelle; N Giard; R Maltais; J Delorme; M Brazeau
Journal:  Can Med Assoc J       Date:  1982-10-15       Impact factor: 8.262

Review 5.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

6.  Cryptococcal meningitis.

Authors:  T L Tjia; Y K Yeow; C B Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

Review 7.  Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.

Authors:  C A Lyman; T J Walsh
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

8.  L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis.

Authors:  P Dobrick; K Miksits; H Hahn
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

9.  Cryptococcus meningitis, clinical--CT scan considerations.

Authors:  C T Tan; B B Kuan
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

10.  Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome.

Authors:  F Bahls; S M Sumi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.